Clinical Trial Update: Safety and Tolerability of Once-daily Oral Aripiprazole in Children and Adolescents With Tourette's Disorder [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the safety and tolerability of once-daily oral aripiprazole in children and adolescents with Tourette syndrome and related tic disorder…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tic Disorders
• Tourette Syndrome

Drugs mentioned

• Abilify (aripiprazole)

Snippet

Sponsor: Otsuka Pharmaceutical Development & Commercialization, Inc. | Conditions: Tourette's Disorder, Tic Disorder | Phase 3 | Status: COMPLETED | Results posted: 2015-10-16